NewLink Genetics Corp. Reaches New 12-Month High at $42.14 (NLNK)
NewLink Genetics Corp. (NASDAQ:NLNK)’s share price hit a new 52-week high during mid-day trading on Monday , StockRatingsNetwork reports. The stock traded as high as $42.14 and last traded at $41.95, with a volume of 537,490 shares traded. The stock had previously closed at $38.68.
NLNK has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus raised their price target on shares of NewLink Genetics Corp. from $31.00 to $53.00 in a research note to investors on Wednesday, January 22nd. They now have a “buy” rating on the stock. They noted that the move was a valuation call. Five research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus target price of $31.20.
The stock has a 50-day moving average of $29.10 and a 200-day moving average of $21.05. The company’s market cap is $1.077 billion.
NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.